KMU is pleased to announce its participation in BIO Asia–Taiwan 2026, Asia's premier biotechnology conference and exhibition. The event will be held July 15–19 at the Taipei Nangang Exhibition Center, TaiNEX 1 & 2. This year's theme, "Asian Inspiration, Global Impact," highlights the integrative power of innovation together with AI to connect Asia with global networks, investment, regulation, and supply chains. 

KMU will present over 50 cutting-edge research innovations spanning two key domains — Drug & Cosmetic Development and Medical Devices & Biotech — including novel cancer therapeutics, AI-powered medical imaging, precision drug delivery platforms, intelligent surgical assistance systems, and skin regeneration technologies. Each innovation has been developed by KMU's world-class research teams, validated through rigorous academic and clinical processes, and carries strong commercialization potential.

With over 70 years of medical excellence, KMU is actively pursuing international collaboration and licensing opportunities. We warmly invite global industry partners to visit our booth N525A, and explore the possibilities of licensing, technology transfer, and joint R&D."

For the full technology portfolio, visit: 2026 KMU IP Portfolio: https://shorturl.at/oFxtr